IS DETAILING OF PRODUCT INFORMATION NOT A NECESSARY PART OF DOCTORS PROFESSIONAL ENHANCEMENT?
Yes, but with a qualified tag. Many doctors prohibit or passively avoid seeing Drug Reps. The current interface has been shown to be totally unsatisfactory due to several factors. Doctors have to run a business as well as a profession. The costs of consultation infrastructure now ordain that detailing access is now qualified by adverse factors of time, quality of attentiveness and loss of displaced consulting income. Product information is presented in a biased and unchallenged manner and the rather bland undecorated data sheet is supposed to serve the purpose of informing the prescriber about adverse effects which are rarely alluded to in the detailing presentation. Unfair and exaggerated claims of benefits, on the other hand, are presented in full glorious colour lamination. None of this tactical manoeuvering enhances the prescribers information or alerts him to adverse outcomes for his patient. The presentation of side-effects should be as efficacious and transparent as supposed ben
